Progesterone and Luteinizing hormone secretion patterns in early pregnant gilts

We studied luteinizing hormone (LH) pulsatility and episodic progesterone release of the corpus luteum (CL) on Day 11 and Day 21 in inseminated gilts and aimed to establish a relationship between these two hormones. Blood was collected at 15-min intervals for 12 hr on Days 11, 16 and 21 from a vena cava caudalis catheter. At euthanasia, eight gilts were pregnant and six gilts were not pregnant. Progesterone parameters (basal, mean, pulse frequency and pulse amplitude) did not differ between pregnant and non-pregnant gilts on Day 11, LH pulse frequency and amplitude tended to differ (p = .07 and p = .079). In pregnant gilts, basal and mean progesterone, progesterone pulse amplitude and frequency declined significantly from Day 11 to Day 21 (p < .05). A significant decline was also seen in the LH pulse amplitude from Day 11 to Day 21 (p < .05). None of the LH pulses was followed by a progesterone pulse within 1 hr on Day 21. On Day 11 and Day 21 appeared a synchronicity in the LH pulse pattern, as there were two or three LH pulses in 12 hr and these LH pulses appeared in the same time window. We conclude that on Day 11 and Day 21 of pregnancy in gilts, progesterone pulses do not follow an LH pulse within one hour. Further we demonstrated that the successful or not successful formation of a CL of pregnancy is independent of progesterone release on Day 11 after insemination. We confirmed the decline of progesterone from Day 11 to Day 21 in the vena cava caudalis and could demonstrate that this decline is partly due to lower progesterone pulse amplitude and frequency and that the decline occurs simultaneously with a decline in LH pulse amplitude.     

Nitrogen requirement of pregnant gilts

Eleven Yorkshire x Landrace gravid gilts were used in two Latin square trials to determine the N requirement for pregnancy. Semipurified diets were formulated to be adequate in indispensable amino acids (IAA) and other nutrients. Diets were fed once daily (1.82 kg); L-glutamic acid, corn sugar, powdered cellulose, and soybean oil percentages differed to maintain isocaloric diets. In Trial 1, six gilts were fed diets containing 6.6 to 17.2% CP equivalent (19.2 to 50.1 g of N/d) during six 10-d periods beginning on d 40 postcoitum. In Trial 2, five gilts were fed diets containing 4.3 to 12.6% CP equivalent (12.5 to 36.8 g of N/d) during five 10-d periods beginning on d 50 postcoitum. Nitrogen balance trials were conducted during the last 5 d of each period. Blood samples were taken both before and 3 h after the last feeding of each period. Results from Trial 1 suggested that adequate N retention (10 g/d) could be attained by pregnant gilts fed less than 28 g of N/d intake when the diet contained indispensible amino acids at levels suggested by Nutrient Requirements of Swine (NRC, 1988). An intake of 20.6 g of N/d (7.1% CP equivalent) yielded near maximum N retention among pregnant gilts fed the semipurified diets in Trial 2. Other criteria measured (urine urea nitrogen and plasma urea nitrogen) had limited value in the evaluation of the N status of the pregnant gilts in these trials.     

Endotoxin-induced abortion in early pregnant gilts and its prevention by flunixin meglumine

The objective of the study was to examine the effect of endotoxin on early pregnancy in gilts and to test the potential of flunixin meglumine (FM), a cyclooxygenase inhibitor, to counteract abortifacient action of the endotoxin. Ten gilts at 30 days gestation were used in the experiment. Eight were injected with lipopolysaccharide (LPS) of Salmonella typhimurium, while 2 were treated with 500 micrograms cloprostenol (CP). Six of the LPS-injected gilts were treated with a total of 4 mg/kg body weight FM in 2 different dose regimens. Clinical observations were recorded and plasma levels of 15-keto-13, 14-dihydro-PGF2 alpha, progesterone and estrone sulfate (ES) were determined with radioimmunoassay. LPS induced typical signs of endotoxemia and a monophasic fever in all LPS-treated gilts. No antipyretic effect of FM was observed. The CP-treated gilts aborted within 34 h as did the gilts treated by LPS only. Of the 6 LPS + FM-treated gilts, 1 aborted within 34 h, while 5 maintained gestation. These were aborted about a week later by CP and the aborted fetuses anatomically examined. Two of the litters were lost (devoured by the dams), 2 showed no signs of earlier death and 1 showed extensive fetal death. The PGF2 alpha metabolite concentrations increased at least 10 fold immediately after the LPS injection. Progesterone plasma concentration decreased rapidly. A 5-10 fold increase in the plasma metabolite levels accompanied all abortions. CP caused no immediate change in the PGF2 alpha metabolite levels, but the abortion-related response was similar to that in LPS-injected gilts. In the FM-treated gilts, the LPS-induced PGF2 alpha metabolite response was rudimentary and the progesterone decrease temporary in nonaborting gilts. The elevated concentrations of ES decreased within 48 h in gilts aborting at 30 days gestation, while in nonaborting gilts a slow, graduate decrease of ES occurred within 3-5 days of the LPS injection. These results indicate that FM apparently suppressed LPS-induced prostaglandin synthesis and thus prevented luteolysis and abortion in early pregnant gilts.     

Pituitary responsiveness to GnRH, hypothalamic content of GnRH and pituitary LH and FSH concentrations immediately preceding puberty in gilts

To determine whether pituitary concentrations of luteinizing hormone (LH), follicle-stimulating hormone (FSH) or hypothalamic content of gonadotropin releasing hormone (GnRH) change before puberty, 40 prepubertal gilts averaging 7 mo of age were slaughtered before or on the second, third or fourth day after relocation and boar exposure. Some gilts responded to relocation and boar exposure as indicated by swollen vulvae, turgid uteri and enlarged ovarian follicles at the time of slaughter. Pituitary concentrations of LH and FSH and hypothalamic content of GnRH were similar between gilts that responded to relocation and boar exposure and gilts that did not respond. In addition, boar exposure and relocation had no effect on pituitary concentrations of LH and FSH or on hypothalamic content of GnRH. To determine whether pituitary responsiveness to GnRH changes before puberty, a third experiment was conducted in which 72 gilts were injected with 400 micrograms of GnRH either before or on the second, third or fourth day after relocation and boar exposure. In gilts that subsequently responded (i.e., ovulated) as a result of relocation and boar exposure, pituitary responsiveness to GnRH was reduced as compared with gilts that failed to ovulate after relocation and boar exposure. Peak concentrations of serum LH after GnRH injection were 4.6 +/- 1.3 vs 9.8 +/- .8 ng/ml for responders vs nonresponders. Peak serum FSH after GnRH injection was also lower for responders than for nonresponders (29.5 +/- 4.2 vs 41.2 +/- 2.4 ng/ml). When compared with controls, relocation and boar exposure did not significantly affect GnRH-induced release of LH and FSH.(ABSTRACT TRUNCATED AT 250 WORDS)     

GnRH‐agonist deslorelin implant alters the progesterone release pattern during early pregnancy in gilts

The aim of this study was to investigate the relationship of progesterone (P) and luteinizing hormone (LH) during recognition and establishment of pregnancy in the gilt. Therefore, the effects of eliminating episodic LH pulses on P patterns were determined during early pregnancy. To this end, a slow‐release GnRH implant deslorelin was used for GnRH down‐regulation. A group of gilts (GnRHa, n = 8) was implanted with the GnRH‐agonist on Day 11 of pregnancy, while a control group (C, n = 5) was treated with a non‐impregnated placebo implant. Blood was collected via a vena cava caudalis catheter at 10‐min intervals for 8 hr on Day 16 and 21 of pregnancy. As expected, the GnRH implant reduced LH secretion (p < 0.01) and abolished LH pulses completely at Day 16 and Day 21 of pregnancy. On Day 16, there was no difference in P levels between the treatments. However, on Day 21, the GnRH‐agonist treatment led to significantly increased P concentrations (p < 0.01) compared with the control gilts. Progesterone was secreted in a pulsatile manner in both treatment groups and no relationship between LH pulsatility and P pulsatility was observed. In conclusion, abolishment of LH pulsatility did not affect the pulsatile pattern of P secretion but led to an unexpected overall increase in P on Day 21 of pregnancy; this effect was delayed and occurred 10 days after commencing treatment with the GnRH depot agonist. The elevation of P on Day 21 of pregnancy in the GnRHa group suggests either a reduced negative feedback effect or an increased autocrine response by the corpora lutea.     

Endocrine responses and ovarian changes in inseminated dairy heifers after an injection of a GnRH agonist 11 to 13 days after estrus.

Our objective in this study was to determine endocrine responses and changes in ovarian structures after a single injection of a GnRH agonist in Holstein dairy heifers (n = 38). Heifers were inseminated and received (i.m.) either saline or 200 micrograms of fertirelin acetate once on d 11, 12, or 13 after estrus (d 0). Blood was collected at 15- to 30-min intervals for 6 h after the injection to determine concentrations of LH, FSH, estradiol (E), and progesterone (P) in serum and once daily for 8 to 12 d after the injection to determine concentrations of E and P. Pregnancy rates were 58% (11 of 19) in both treatment groups. Diameter of the corpus luteum and numbers and appearance of ovarian follicles were determined by real-time ultrasonography on d-1 through 5 after injection. No treatment-induced ovulations or changes in the number of ovarian follicles were observed after the injection of the GnRH agonist. More (P less than .05) of the largest follicles within heifers receiving fertirelin acetate showed changes in their appearance on at least the 1st d after injection (6 of 10 vs 1 of 9 control heifers). Fertirelin acetate induced release of LH and FSH from the pituitary within 15 min of injection; both hormones reached peak concentrations at 120 min and then returned to pretreatment concentrations by 300 to 360 min after injection.(ABSTRACT TRUNCATED AT 250 WORDS)     

Characterization of mammary gland development in pregnant gilts

The purpose of this study was to quantify mammary gland (MG) growth during pregnancy in gilts and to determine the effect of anatomical location on gland growth. Size, composition, and histomorphology of MG were determined during gestation in 29 primigravid gilts. Gilts were allotted randomly to 6 slaughter groups: d 45 (n = 6), 60 (n = 4), 75 (n = 5), 90 (n = 4), 102 (n = 5), and 112 (n = 5) of gestation. Mammary glands were obtained at slaughter, and skin and extraneous fat pad were removed to obtain parenchymal MG tissue. Mammary glands were further separated into individual MG, and their locations were recorded. Individual MG were weighed and bisected in an approximate midsagittal section to measure cross-sectional area. Mammary glands were ground individually and pooled according to anatomical region: the first and second pairs of MG = anterior MG; the third, fourth, and fifth pairs of MG = middle MG; the sixth, seventh, and eighth pairs of MG = posterior MG. Contents of DM, CP, ether extract, and crude ash were measured. Wet weight, DM, CP, and ash content of total and individual MG increased (P < 0.01) between d 45 and 112 of gestation. Cross-sectional area of individual MG increased (P < 0.01) as gestation progressed. Percentage of CP and ash increased (P < 0.01), whereas percentage of ether extract decreased (P < 0.01) as gestation progressed. This inverse relationship between percentages of CP and ether extract (r = -0.999; P < 0.0001) was consistent with the histological shift from primarily an adipose tissue in early gestation to one containing extensive lobuloalveolar tissue in late gestation. Wet weight of middle MG was greater (P < 0.05) than that of posterior MG at d 102 and 112 of gestation, and amount of CP in middle MG was greater (P < 0.05) than that in anterior and posterior MG at d 102 and 112 of gestation, indicating that middle MG grow faster than other MG during late gestation. Rates of wet weight gain and protein accretion were accelerated (P < 0.01) after d 74 and 75 of gestation, respectively, indicating the importance of MG growth during the last trimester of gestation. The increase in rate of protein accretion after d 75 indicates a greater protein requirement for MG growth during later gestation.     

Pulsatile administration of gonadotropin-releasing hormone agonist to gilts actively immunized against gonadotropin-releasing hormone

Sexually mature gilts (n = 20) were actively immunized against GnRH. Primary and booster immunizations of GnRH conjugated to bovine serum albumin induced production of antibodies in all gilts. Nineteen of the gilts became acyclic with suppressed concentrations of gonadotropins and estradiol. Intravenous challenges with 100 micrograms GnRH and 5 micrograms D-(Ala6, des-Gly-NH2(10)) ethylamide GnRH (a GnRH agonist that did not cross-react with antibodies produced by the gilts) caused release of LH and FSH, indicating maintenance of secretory capacity of pituitary gonadotropes in the immunized animals. Gilts were given 100 ng GnRH agonist at 2-h intervals for 72 h (n = 4) or 144 h (n = 10) or did not receive agonist (n = 5). Blood samples were taken every 6 h, and detectable concentrations of LH were observed in 42% and 52% of samples taken from gilts treated with or without agonist. In contrast, serum concentrations of FSH and estradiol were undetectable. Reproductive tracts and anterior pituitaries were taken from gilts at the conclusion of pulsatile administration of GnRH agonist or at 144 h for controls. Pituitary concentration of LH and FSH, uterine wet and dry weight, and size of the uterus were similar among groups. Paired ovarian weights for treated gilts pulsed with GnRH agonist for 72 h were heavier (P less than .05); however, ovaries from all immunized gilts were atrophied without follicular structures.(ABSTRACT TRUNCATED AT 250 WORDS)     

Reproductive performance of early postpartum Holstein cows where oestrus was synchronised following chronic GnRH agonist treatment

OBJECTIVE: The objectives of this study were: to compare the recovery of follicular development in early postpartum cows that had been treated for 7, 14 or 21 d with implants containing the GnRH agonist deslorelin; to evaluate the effectiveness of human chorionic gonadotrophin (hCG) for the induction of ovulation when a follicle was at least 10 mm in diameter following implant removal; and to compare final pregnancy rates for treated cows and untreated contemporaries. PROCEDURE: Within 3 d of calving Holstein cows were allocated to receive a single subcutaneous deslorelin implant to be left in place for either 7, 14 or 21 d, or to remain untreated as controls. Every deslorelin treated cow was monitored twice weekly for 35 d to determine the interval from implant removal to resumption of ovulation using serial transrectal ultrasonography and plasma progesterone assay. An injection of 1000 IU hCG was given to induce ovulation when a follicle of at least 10 mm diameter was first observed. Oestrous cycles of every cow were synchronised to facilitate artificial insemination (Al) at the start of the seasonally concentrated Al program and resynchronised for three rounds. Pregnancy testing was performed by ultrasonography 13 weeks after the first round of Al. RESULTS: Deslorelin implants inhibited ovulation for at least 10 d after they were removed. Ovarian follicles were smaller for the group that had implants for 21 d at the time of implant removal. Eighteen cows selected for treatment with hCG ovulated and formed multiple corpora lutea within 7 d. There was no effect of treatment duration on final pregnancy rates. After three rounds of AI the pooled final pregnancy rate for every cow that had received a deslorelin implant was similar to the rest of the herd (67% versus 63%; Deslorelin versus Herd, P > 0.1).The interval from start date of the AI program to conception was also unaffected by treatment (9.6 +/- 3.0 versus 14.8 +/- 1.7 d; Deslorelin versus Herd; P > 0.1). CONCLUSION: No significant effect was detected on the interval from implant removal to first ovulation by altering the duration of deslorelin treatment. Treatment with hCG when a follicle at least 10 mm in diameter was present induced ovulation in most cases. Although no significant improvement in fertility was found, a larger field trial using this model for induced anoestrous is necessary before any effect on fertility could confidently be stated.     

Response of nonpregnant versus pregnant gilts and their fetuses to severe feed restriction

Crossbred (Chester White X Landrace X Large White X Yorkshire) primiparous gilts were fed a standard gestation diet at 6,000 or 2,000 kcal calculated digestible energy (DE; 1.8 or .6 kg feed) daily for 84 or 108 (106 to 112) d after mating. Nonpregnant littermates were matched by body weight and assigned to the same diet treatments. Body weight and ultrasonic backfat measurements were made at 3-wk intervals. At 77 and 100 d, eight pregnant gilts (four control and four restricted) were fitted with indwelling jugular cannulas for frequent blood sampling (33 times over an 8-h period) to determine plasma glucose and growth hormone concentrations. At 84 and 108 d all gilts (eight pregnant and eight nonpregnant at d 84 and nine pregnant and nine nonpregnant at d 108 for each diet) were slaughtered and internal organs and reproductive tracts were removed and weighed. Fetal body and organ weights were recorded and an umbilical artery blood sample was removed from fetuses for plasma glucose, growth hormone, total protein and albumin measurements. The results demonstrated the ability of the primiparous gilt to maintain pregnancy through 106 to 112 d of gestation while consuming one-third (2,000 kcal DE daily) of recommended daily feed. Fetal weight at 84 and 108 d was reduced by about 13% without affecting litter size in gilts fed severely restricted intakes. Absolute and relative weights of maternal organs were affected by severe feed restriction, and backfat was reduced but there was no evidence of "pregnancy anabolism" in either adequately fed or restricted gilts. Fetal liver, kidney and gastrointestinal tract weights were reduced by maternal feed restriction; relative kidney weights were reduced while relative brain cortex weight was increased by maternal restriction. Maternal plasma glucose was unchanged by pregnancy or feed intake while plasma growth hormone peak amplitude, but not mean concentration or number of peaks, was increased by feed restriction. Fetal plasma glucose increased with time and in response to severe maternal feed restriction while plasma total protein and albumin decreased. Plasma growth hormone declined with time and was negatively correlated with fetal body weight.     

Response of gilts with delayed puberty to pregnant mare serum gonadotropin or estrogen

The effect of pregnant mare serum gonadotropin (PMSG) or estradiol cyclopentylpropionate (EC) on the induction of estrus, duration of estrus, and serum progesterone concentration after estrus was evaluated in 8 gilts with delayed puberty. Four gilts were given 500 IU of PMSG IM and 4 were given 2 mg of EC, IM. The inactive status of the ovaries at the time of treatment was verified by serum progesterone values of less than 0.5 ng/ml in serial samples collected before treatment. The 4 EC-treated gilts came into estrus at a mean of 3.5 days after treatment, but 1 of the gilts did not form corpora lutea. Three PMSG-treated gilts came into estrus at a mean of 4.0 days after treatment. The remaining PMSG-treated gilt remained anestrus and did not form corpora lutea. The mean duration of estrus in EC-treated gilts was 5.25 days compared with 2.0 days for PMSG-treated gilts (P less than 0.05). Serum progesterone concentrations were higher in PMSG-treated gilts than in EC-treated gilts at 8, 11, and 17 days after treatment (P less than 0.05).     

Experimental infection of pregnant gilts with swine hepatitis E virus

To determine the effect of swine hepatitis E virus (HEV) infection on pregnant gilts, their fetuses, and offspring, 12 gilts were intravenously inoculated with swine HEV. Six gilts, who were not inoculated, served as controls. All inoculated gilts became actively infected and shed HEV in feces, but vertical transmission was not detected in the fetuses. There was no evidence of clinical disease in the gilts or their offspring. Mild multifocal lymphohistiocytic hepatitis was observed in 4 of 12 inoculated gilts. There was no significant effect of swine HEV on fetal size, fetal viability, or offspring birth weight or weight gain. The offspring acquired anti-HEV colostral antibodies but remained seronegative after the antibodies waned by 71 days of age. Swine HEV infection induced subclinical hepatitis in pregnant gilts, but had no effect on the gilts' reproductive performance, or the fetuses or offspring. Fulminant hepatitis associated with HEV infection was not reproduced in gilts.     

Hourly administration of GnRH to prepubertal gilts: endocrine and ovulatory responses from 70 to 190 days of age.

This study investigated the responsiveness of the pituitary-ovarian axis of prepubertal gilts to hourly injections (i.v.) with GnRH. Six gilts each at 70, 100, 150, and 190 d of age were assigned either to treatment with GnRH or saline. Treatments were given until gilts showed estrus or for 7 d, whichever came first. Hourly pulsing with GnRH resulted in gradually increasing concentrations of estradiol-17 beta (E2), a preovulatory surge of LH, and subsequently increased progesterone (P4) concentrations. The increase in serum P4 was preceded by ovulation and corpora lutea (CL) formation in two gilts 70 d of age and all older gilts. The interval (h) from start of GnRH treatment to peak E2 (88 +/- 3), peak LH (103 +/- 3), and concentrations of P4 greater than or equal to 1 ng/mL (144 +/- 4) did not differ (P greater than .50) for 18 gilts between 100 and 190 d of age. In two ovulating, 70-d-old gilts, the interval from onset of GnRH treatment to peak E2 (171 +/- 6), peak LH (186 +/- 0), and P4 greater than or equal to 1 ng/mL (216 +/- 4) was lengthened (P less than .001). Peak concentrations of E2 (pg/mL) were higher (P less than .01) at 190 d (48 +/- 2) and 150 d (49 +/- 2) than at younger ages and lower (P less than .01) in gilts 70 d of age (31 +/- 1) than in gilts 100 d of age (41 +/- 2). Peak LH (nanograms/milliliter) was higher (P less than .01) in gilts 100 d of age (12.7 +/- 6) than in older gilts. Concentrations of P4 were similar (P greater than .20) for all ovulating gilts. The number of CL (12.7 +/- .7) did not differ (P greater than .20) for 18 gilts 100 d of age or older but was higher (P less than .01) than that (4.5 +/- 1.1) for two gilts 70 d of age. Corresponding endocrine responses or ovulations were not observed in four 70-d-old gilts treated with GnRH or in gilts given saline. These findings indicate that the functional integration of the pituitary-ovarian axis is completed between 70 and 100 d of age. Hourly treatment with GnRH is an adequate stimulus to induce ovulation in prepubertal gilts as early as 70 d of age. Also, the number of follicles reaching ovulatory competency was similar (P greater than .20) in gilts between 100 and 190 d of age, when GnRH was given on a BW basis.     

Experimental infection of pregnant gilts with Leptospira interrogans serovar mozdok.

Three pregnant gilts were experimentally infected with leptospires of the serovar mozdok, isolated from an aborted pig fetus from a Portuguese pig farm with abortion problems. All the gilts aborted dead or dying piglets on days 105 or 106 of pregnancy. Serovar mozdok was isolated from 12 of the 22 piglets in the three litters. Histological examination of the livers and kidneys of the gilts at the end of the experiment revealed evidence of disease, and leptospires were isolated from their kidneys. Their serological responses up to 42 days after inoculation were monitored by means of a microscopic agglutination test, using 21 antigens from 18 serogroups. Cross reactions to heterologous antigens belonging to the Grippotyphosa, Australis, Icterohaemorrhagiae and Cynopteri groups were observed in all of them.     

Factors contributing to early embryonic mortality in gilts bred at first estrus

Gilts bred at first (n = 18) and third (n = 18) estrus were assigned in replicates of equal numbers to be slaughtered on d 3, 15 and 30 post-mating to assess fertilization rate, embryonic losses and serum concentrations of estrogen (estradiol-17 beta + estrone) and progesterone. Mean number of ovulations was lower among gilts bred at first vs third estrus (12.2 vs 14.5; P less than .05), with no difference in fertilization rate (100 vs 98%). Embryonic survival was lower (P less than .05) among gilts bred at first vs third estrus on d 15 (78.1 vs 95.4%) and 30 (66.7 vs 89.4%) of gestation. Serum estrogen (pg/ml) and progesterone (ng/ml) levels, although lower in gilts bred at first vs third estrus, were not significantly different at the three stages of gestation studied. The ratio of progesterone to estrogen in gilts bred at first estrus was higher than in those bred at third estrus on d 15 (439 +/- 71 vs 210 +/- 17) and 30 (597 +/- 106 vs 179 +/- 50), but was lower on d 3 (187 +/- 37 vs 444 +/- 123; stage of gestation X estrous period interaction, P less than .05). These data suggest that changes in the ratio of systemic levels of estrogen and progesterone may be related to early embryonic mortality in gilts bred at pubertal estrus.